Capitol Family Dental Clinic in Milwaukee, Wisconsin
-
Aurora Bay Area Prices – CANCER ANTIGEN 19-9 is $215
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10001298, regarding CANCER ANTIGEN 19-9, which is classified under revenue code 302 and associated with CPT code 86301, the designated fee stands at $215. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Sheboygan Prices – INJECT SPINE W/CATH L/S + IMAGING is $3,860.00
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10003666, regarding INJECT SPINE W/CATH L/S + IMAGING, which is classified under revenue code 360 and associated with CPT code 62327, the designated fee stands at $3,860.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Bay Area Prices – MEPERIDINE RANGE INJ is $10.43
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding MEPERIDINE RANGE INJ, which is classified under revenue code 250 and associated with CPT code J2175, the designated fee stands at $10.43. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Do you need Lp(a) testing? New heart-risk guidance changes the conversation
The American Heart Association’s new dyslipidemia guidance puts lipoprotein(a), or Lp(a), on more clinicians’ radar. For many adults, the test is meant to refine heart-risk assessment — not replace a standard cholesterol panel or by itself tell you whether you need treatment. That matters because Lp(a) is usually inherited, often does not cause symptoms, and is not checked on routine cholesterol tests. The new guidance says a one-time measurement may help identify people whose risk is higher than their usual LDL cholesterol result suggests.